GLF
WST icon

Groupe la Francaise’s West Pharmaceutical WST Stock Holding History

Groupe la Francaise’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20
Closed -$4.43K – 789
2025
Q3 		$4.43K Buy
+20
New +$4.86K ﹤0.01% 654
2025
Q2 		– Sell
-677
Closed -$153K – 504
2025
Q1 		$153K Sell
677
-8,019
-92% -$2.21M ﹤0.01% 370
2024
Q4 		$2.88M Buy
+8,696
New +$2.74M 0.07% 161

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Groupe la Francaise's WST Position: Q4 2025 in Review

Groupe la Francaise sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 20 shares — an estimated $4.43K sold.

Groupe la Francaise first reported a position in WST in Q4 2024 and held it in 3 quarters. The position peaked at $2.88M in Q4 2024. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • Groupe la Francaise reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Groupe la Francaise sold 20 West Pharmaceutical shares in Q4 2025, an estimated $4.43K.
  • Groupe la Francaise first reported a position in West Pharmaceutical in Q4 2024 and held it in 3 quarters.
  • Groupe la Francaise's West Pharmaceutical position peaked at $2.88M in Q4 2024.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.